Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H17F3N2O2 |
InChIKeyRXVOFPXZHVKZIL-UHFFFAOYSA-N |
CAS Registry1195786-61-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | FR | 18 Jul 2012 |